Does human milk reduce infection rates in preterm infants? A systematic review
- 1Neonatology Unit, University Hospital of North Staffordshire, Stoke on Trent, UK
- 2School of Computing and Mathematics, Keele University, Staffordshire, UK
- Correspondence to:
Dr S A Spencer
Neonatal Unit, University Hospital of North, Staffordshire, Newcastle Road, Stoke-on-Trent ST4 6QG, UK; andy.spenceruhns.nhs.uk
- Accepted 15 May 2004
Abstract
One of the reasons for advocating human milk (HM) feeding for preterm infants is the belief that this provides the infant with a degree of protection from infection. Providing fresh HM for such infants is challenging for mothers and staff, and consequently it is important that its benefits are rigorously evaluated. Therefore a systematic review was undertaken to assess all publications concerned with human milk feeding and infection in very low birth weight (VLBW) preterm infants. Nine studies—six cohort and three randomised controlled trials (RCT)—were assessed using predefined criteria. Methodological problems included poor study design, inadequate sample size, failure to adjust for confounding variables, and inadequate definitions of HM feeding and outcome measures. In conclusion, the advantage of HM in preventing infection in preterm, (VLBW) infants is not proven by the existing studies. Recommendations are made regarding the methodology required for further study of this important topic.
- ELBW, extremely low birth weight
- HM, human milk
- RCT, randomised controlled trial
- UTI, urinary tract infection
- VLBW, very low birth weight
